Predicting malignancy in mediastinal lymph nodes by endobronchial ultrasound: A new ultrasound scoring system
Gerald Schmid‐Bindert(Heidelberg University), Lothar R. Pilz(Heidelberg University), Caicun Zhou(Tongji University), Hao Wang, Thomas Henzler(Heidelberg University), Hongbin Jiang, Shengxiang Ren(Tongji University), Georg Kähler, Joachim Saur(TH Köln - University of Applied Sciences)
Cited by 66
Related Papers
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
|The Lancet Oncology|2011|4.1k
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
|The Lancet|2021|1.5k
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|504
Transient Water Vapor at Europa’s South Pole
|Science|2013|498